Avenue Therapeutics Inc. (ATXI)
NASDAQ · Healthcare
Avenue Therapeutics Inc. Net Income 2024–2025
Avenue Therapeutics Inc. annual/quarterly net income history and growth rate from 2024 to 2025. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Avenue Therapeutics Inc. net income for the quarter ending September 30, 2025 was -683000, a 77.80% decrease year-over-year.
- Avenue Therapeutics Inc. net income for the twelve months ending September 30, 2025 was -6.1 M.
- Avenue Therapeutics Inc. annual net income for 2025 was -2.9 M, a 75.03% decrease from 2024.
- Avenue Therapeutics Inc. annual net income for 2024 was -11.7 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Avenue Therapeutics Inc. Net Income — FAQ
Avenue Therapeutics Inc. (ATXI) net income over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Avenue Therapeutics Inc.'s net income?
Avenue Therapeutics Inc. (ATXI) reported net income of -$3M for fiscal 2025.
Where can I see ATXI's net income history?
The chart and table above show Avenue Therapeutics Inc.'s net income by year and by quarter, including the growth rate.